ResMed
RMD
235.63
-1.25
-0.53%
ResMed
US · RMD
#644 by market cap
Listed 1970
235.63
-1.25
-0.53%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of ResMed Inc. (NYSE: RMD).PR Newswire · 2026/11/10
-
Rating change
Stifel Maintains ResMed(RMD.US) With Hold RatingMarket Newswire · 2026/9/25
-
A Quick Look at Today's Ratings for ResMed(RMD.US), With a Forecast Between $260 to $288Market Newswire · 2026/10/31
-
UBS Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)TipRanks · 2026/10/21
-
Citi Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $270Market Newswire · 2026/11/2
-
Company notice
ResMed Inc: LR 1.15.3 ComplianceASX · 2026/8/28
-
Rating change
ResMed Price Target Raised 1.5% to A$47.50/Share by MacquarieDow Jones · 2026/11/2
-
Mizuho Securities Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $240Market Newswire · 2026/10/13
-
Company notice
8-K: Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026SEC · 2026/5/1
-
Rating change
Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Buy From Canaccord GenuityTipRanks · 2026/9/29
-
Company notice
8-K: Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026SEC · 2026/8/7
-
Rating change
Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Receives a Buy From Ord MinnettTipRanks · 2026/10/5
-
Rating change
Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD) Gets a Hold From CitiTipRanks · 2026/10/19
-
Company notice
8-K: Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026SEC · 2026/1/30
-
Rating change
ResMed Price Target Raised 3.6% to US$233.00/Share by Morgan StanleyDow Jones · 2026/10/22
-
Rating change
ResMed Cut to Accumulate From Buy by Morgans RMD.AUDow Jones · 2026/11/3
-
Company notice
8-K: Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027SEC · 2026/10/30
-
Rating change
ResMed Price Target Raised 3.6% to A$37.50/Share by BarrenjoeyDow Jones · 2026/11/2
-
Rating change
Citi Sticks to Its Hold Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)TipRanks · 2026/10/16
-
Rating change
Stifel Maintains ResMed(RMD.US) With Hold Rating, Announces Target Price $235Market Newswire · 2026/10/2
-
ResMed Target Price Raised 1.3% to A$40.00/Share by MorgansRMD.AUDow Jones · 2026/11/3
-
Don't Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain -- Barrons.comBarron's · 2026/11/5
-
Company notice
8-K: Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026SEC · 2025/10/31
-
Morgan Stanley Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (RMD)TipRanks · 2026/10/23
-
Rating change
Citi Maintains ResMed(RMD.US) With Hold Rating, Raises Target Price to $240Market Newswire · 2026/9/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.
ResMed discussion 0 comments